If you are looking for the Anthem stock price today, you might notice something a little weird when you type that ticker into your brokerage app. Anthem isn't actually "Anthem" anymore on the New York Stock Exchange. Back in 2022, the company rebranded to Elevance Health and started trading under the ticker ELV.
So, if you’re seeing the name Elevance pop up, don’t panic. It's the same massive blue-chip health insurer, just with a fresh coat of paint and a much broader focus than just traditional insurance.
💡 You might also like: S\&P 500 PE Multiple: What Most People Get Wrong About Market Valuation
What is happening with the Anthem stock price today?
Today, January 15, 2026, the market is showing some genuine life for ELV. As of the closing bell, the stock is sitting at $382.05, which is a solid jump of about 2.47% from yesterday’s close of $372.84.
Honestly, it's been a bit of a rollercoaster lately. We saw the stock dip into the $365 range earlier this morning, which probably had some day traders sweating. But the recovery was quick. Volume has been steady, with over 1.5 million shares changing hands. Investors seem to be reacting to a mix of things, including some bullish analyst notes and a general "relief rally" in the healthcare sector.
The 2026 Outlook: Why the hype?
Why is everyone talking about this right now? Well, 2025 was a bit of a rough patch for managed care. We had all these issues with Medicaid redeterminations—basically, states kicking people off the rolls after the pandemic rules ended—and it hit companies like Elevance hard.
But 2026 is looking different.
Wolfe Research recently upgraded the stock to "Outperform." Their analyst, Justin Lake, basically said that 2025 was the "bottom" for earnings. When a big-name analyst says the worst is over, the big money starts flowing back in. They’ve set a price target of $425, which is a pretty decent upside from where we are right now.
The Medicaid headache and the recovery
You've probably heard about the "Medicaid cliff." It sounds scary because, for a company’s bottom line, it sort of was. Elevance manages a ton of Medicaid plans. When the government changed the rules and millions of people lost coverage, it created a massive hole in revenue.
But here’s the thing: those people still need insurance. Many are migrating to the "Exchanges" (Obamacare plans), and Elevance is capturing a huge chunk of that business. They are also being much more disciplined about their Medicare Part D plans. They are actually exiting some lower-margin plans to focus on Medicare Advantage HMOs, which pay better.
Basically, they are trimming the fat.
Breaking down the numbers
It helps to see where the stock has been to know where it's going.
- 52-Week High: $458.75
- 52-Week Low: $273.71
- Current Market Cap: Roughly $82.86 Billion
We are still a ways off from that $458 high, but we are also way up from the $270s. The stock is currently trading at a price-to-earnings (P/E) ratio that looks fairly "cheap" compared to the rest of the S&P 500. For a company that generates as much cash as this one does—we're talking over $5 billion in free cash flow—a low P/E usually attracts the "value" crowd.
Is the rebranding still confusing people?
Kinda, yeah. Even though the name change happened years ago, "Anthem" is such a powerhouse brand that people still search for it. In 14 states, they still use the Anthem Blue Cross Blue Shield name for their actual health plans.
So, while the parent company is Elevance Health, the person using their insurance card in Indiana or California is still looking at a "Blue Cross" logo. It’s a smart move to keep the local brand equity while using the Elevance name to signal to Wall Street that they are doing more than just processing medical claims. They’ve got Carelon, which handles pharmacy and behavioral health, and Wellpoint, which manages their government-funded plans.
💡 You might also like: ENTJ Practice 1 Minute Job Interview: Why Your Efficiency Might Be Killing Your Chances
What the "Smart Money" is doing
If you look at institutional ownership, it’s high. Like, really high—nearly 89%. When the big pension funds and hedge funds own that much of a company, the stock doesn't usually move on a whim. It moves on fundamentals.
Recently, we saw some big updates. Norges Bank (the massive Norwegian sovereign wealth fund) took a huge position. When the world's largest investors are buying the dip, it usually signals a "floor" in the price.
Why the stock jumped this week
Aside from the analyst upgrades, there’s a political angle. Reports are swirling that the administration might extend health insurance premium tax credits for another two years.
If those subsidies stay in place, more people can afford insurance, which means more members for Elevance. It’s a direct tailwind. Plus, the company just added Amy Schulman to their board. She’s a heavy hitter from the healthcare and investment world, and investors usually like seeing that kind of "governance excellence" at the top.
Looking ahead to January 28
Mark your calendars. Elevance is set to report their Fourth Quarter and Full Year 2025 results on January 28, 2026. This is going to be the big "prove it" moment.
Investors want to hear three things:
- Are Medicaid margins finally stabilizing?
- What is the guidance for 2026 earnings per share (EPS)?
- How fast is the Carelon services division growing?
If they beat the estimate of around $3.10 per share for the quarter and provide a sunny outlook for 2026, the stock could easily test those $400 levels again.
Actionable insights for your portfolio
If you're looking at the Anthem stock price today as a potential investment, you've got to weigh the boring (but stable) nature of insurance against the regulatory risks.
Healthcare is always a political football. Every time an election cycle heats up or a new policy is whispered in D.C., these stocks wiggle. But if you are a long-term holder, the "buy the dip" strategy has historically worked well here. The company has a low beta (around 0.51), which basically means it’s less volatile than the overall market. It’s a "defensive" play.
💡 You might also like: سعر اونصة الذهب في امريكا اليوم: لماذا يتحرك المعدن الأصفر بهذا الجنون الآن؟
Keep an eye on the $370 support level. If it stays above that, the upward trend remains intact. If it breaks below, we might be looking for a new "bottom." For most, the dividend yield—currently around 1.8%—is a nice little bonus while waiting for the price to recover.
To stay ahead of the next move, watch the enrollment numbers they release on January 28. Specifically, look at the "Medical Membership" count. If that number is growing despite the Medicaid exits, it’s a massive green flag. Also, keep tabs on any news regarding ACA subsidy extensions, as that is currently the biggest external factor driving the sector's valuation.